Baravan Al-Kassou | MD

Our latest publication @JAHA_AHA investigating the prevalence, impact & strategies for severe multiple valvular heart disease #MVHD in #TAVR: Severe #MR & #TR were prevalent & associated with incr. mortality. Staged #TEER reduced 1- & 5-year mortality ➡️bit.ly/4jH2S0p

@BerkanKurtMD @MReugels @KM_Schneider1 @Transparent_AC @MilziAndrea @wenzl_florian @FudimMarat @LaleTokgozoglu @ehj_ed @cardiotfl @C_V_Schneider Congratulations!

Our article “C-reactive protein and cardiovascular risk in the general population” is now out in the European Heart Journal. In 448 653 adults without ASCVD, a single #hsCRP predicted long-term inflammatory risk and improved SCORE2-based risk prediction. academic.oup.com/eurheartj/adva…

Our latest publication @ejhg_journal on the #genetic architecture of #bicuspid aortic valve (#BAV): Only ~2% of sporadic #BAV patients carry predicted deleterious rare variants in monogenic #BAV genes, suggesting that most #BAV cases are polygenic. bit.ly/4nV9iwB

先日のパリ学会中でのインタビュー JACC cardio. Intervention に掲載された論文の事なんですが、 実は学会で場所が無く、静かな場所を求めて、急遽知人のホテルに転がり込ませてもらって収録した一本

Severe multiple valvular heart disease increases mortality after #TAVR, with tricuspid regurgitation posing the highest risk. Read how staged transcatheter edge‐to‐edge repair improves outcomes. #AHAJournals @bara_doc @UniklinikBonn ahajrnls.org/44ohgX1

🎙️NEW #CRT2025 Interview 💫@bara_doc discusses insights from the GUARD study on the progression and outcomes of mild to moderate #aortic #stenosis. 📽️Watch here👉 ow.ly/qKqK50VfTz9 #CardioEd #CardioTwitter

Fantastic keynote at #CRT2025 by @GeoffMartha, Chairman & CEO of #Medtronic, on the challenges & opportunities for Health Tech companies in this uncertain time of change. Even on the last day, the main arena is packed with engaged & motivated attendees. @CRT_meeting @Medtronic

Prof @ronwaksman expressing heartfelt gratitude to the incredible @CRT_meeting organizing team, who received well-deserved applause from attendees! A fantastic meeting and an unforgettable experience—thank you for making #CRT2024 a success! 👏🏼 #CRTTeam

@CaitlinClark22 takes the stage as keynote speaker at #CRT 2025, greeted by a packed hall of enthusiastic attendees eager to hear from the WNBA star! #CRT2025 @CRT_meeting

Honored to receive a Young Leadership invitation to attend the CRT Meeting 2025. Grateful for this opportunity and excited to engage with fellow leaders and experts at this prestigious event. Looking forward to insightful discussions and learning ahead! @CRT_meeting #CRT2025

In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV

Ihr forscht zum Thema interventionelle Kardiologie? ⬇️EURE CHANCE ⬇️ Noch bis morgen Euer Projekt für den Andreas-Grüntzig-Forschungspreis einreichen ✊ Alle Infos: #accordion-12b035d296-item-4b287380a5" target="_blank" rel="nofollow noopener">herzmedizin.de/fuer-aerzte-un… @AGIKinterv @YoungDgk @DGK_org @Kardiophil @TSchneiderMD @KardiologieHH @bara_doc

SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 bit.ly/4eMWqTe @RoccoMontone @ehj_ed #diabetes

A tale of measured and predicted prosthesis-patient-mismatch #PPM after #TAVR - an analysis of the #IMPPACT TAVI registry by @HenningGuthoff just published in @JACCJournals #JACCInt, accompanied by an editorial of the godfather of PPM @PPibarot bit.ly/3V93T8p 🧵(1/8)

Presented at #AHA24: Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD

Our latest publication @JAMACardio: We identified 17 #AorticStenosis specific genetic loci, including 5 novel loci. Serum #phosphate is a unique AS risk factor. Our findings reveal AS's distinct pathways from #CAD, paving the way for targeted therapies. ➡️bit.ly/4ezb2pq

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Hospitation im Hybrid-Op bei einer #TAVI? 🤩🫀 Von Zugangsweg über Prothesenpräparation bis hin zum Verschlusssystem 👀 Alles eine Frage des #Teamwork 🤝 Hier gibt es das ganze Video: youtu.be/Vtb9CuOY1CA?si… @AtsushiSssugi @bara_doc @MAlZaidi_ @AndreasZietzer @HubrichtD

Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. bit.ly/4eKsVSl #JACC @chrisgraeni

Spannende Session auf den #DGKHerztage|n zur #TAVI Nachsorge – von paravalvulärer Insuffizienz bis hin zu Schrittmacherstrategien und Endokarditis nach TAVI. 💡 Wertvolle Einblicke von Top-Experten! @AGIKinterv @DGK_org @EPTIG @KardiologieHH